UK Parliament Approves Assisted Dying Bill 7500 Could Seek Euthanasia Annually
On June 20, the UK House of Commons narrowly passed the Assisted Dying Bill with a vote of 314 in favor to 291 against, following nearly four hours of heated debate. The bill, known as the Adults with Terminal Illness (End-of-Life) Bill, is now under review by the House of Lords, marking a historic moment in the UK.
The proposed legislation, inspired by Oregon’s assisted dying framework, permits adults in England and Wales diagnosed with terminal illnesses and a life expectancy of less than six months to seek euthanasia. However, it explicitly excludes Scotland and Northern Ireland. Patients must retain the ability to self-administer the medication and secure approval from two doctors and a specialist panel, comprising psychiatrists, social workers, and lawyers.
The bill has sparked intense public and political backlash. Critics argue it could pressure vulnerable groups, such as the elderly and disabled, into prematurely ending their lives. “I believe no one should actively choose to end their own life,” said Anne Marie, a 52-year-old British citizen. Conversely, Adam Bishop, 35, fully supports the bill, stating, “Everyone deserves the right to end their life with dignity.”
Legal experts have expressed concerns over the removal of High Court judge approval, a safeguard included in previous drafts. The Royal College of Psychiatrists, though neutral on euthanasia, opposes the current framework, citing doubts about the qualifications and decision-making abilities of the specialist panel.
The bill has also divided the UK government. While Prime Minister Keir Starmer supports it, Health Secretary Wes Streeting and Justice Secretary Shabana Mahmood have voiced strong opposition, warning of its potential legal and ethical repercussions.
Assisted dying remains illegal in England and Wales, with offenders facing up to 14 years in prison. Over the past two decades, more than 3900 British citizens have traveled to Switzerland to access euthanasia services. Government projections estimate that if the bill is enacted, up to 7500 people could seek assisted dying annually within the next decade.
Looking for chemical products? Let suppliers reach out to you!
2026-07-17
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Zydus Lifesciences Blocked by Delhi High Court in Cancer Biosimilar Case $9.3 Billion Opdyta Patent Dispute Intensifies
-
Novartis Boosts 2025 Earnings Forecast as US Tariff Risks Loom $23 Billion Investment and $10 Billion Buyback Unveiled
-
Bristol Myers’ Reblozyl Misses Main Goal in Cancer Anemia Study $1.77 Billion Drug Faces Setback but Shows Some Benefits
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order
-
Sun Pharma’s Ilumya Hits Primary Endpoint in Two Phase 3 Trials for Psoriatic Arthritis $681 Million Drug Shows Significant Improvement at Week 24
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
McKinsey Pays to Close a Purdue Liability Chapter
Recommend Reading
-
NHU and Sinopec Advance Liquid Methionine Project
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
Reducing to Refocus: Novo Nordisk’s 9,000-Job Cut and the Strategic Realignment in Pharma
-
Novo Nordisk Reports Theft of Six Drug Batches in India Authorities Warn of Severe Patient Safety Risks
-
Coke market mainly maintains stable operation
-
This week, the caustic soda price showed a weak trend (1.19-1.23) in China
-
Polyester Bottle Flakes Show Initial Decline Followed by Rise This Week (Jan. 16–23, 2026)
-
Downstream Buyers Cautious as Independent Refineries' Petroleum Coke Market Continues to Decline
-
Cost and Supply-Side Positives Support Aniline’s Continued Rise